Dr. Ann Nainan from Medicspot provides a three-step plan to help individuals manage weight regain after discontinuing weight-loss injections such as Wegovy and Mounjaro. She emphasizes the importance of gradual withdrawal and maintaining healthy habits to mitigate potential side…
A recent review published in Frontiers in Nutrition highlights that combined diet and exercise interventions yield greater improvements in weight, metabolic health, and fitness co…
Researchers at the Wharton School of the University of Pennsylvania are exploring whether GLP-1 drugs, known for aiding weight loss, can also influence financial behaviors by redu…
Recent developments in weight-loss medications highlight the potential of amylin-based drugs, which may offer effective weight management with fewer gastrointestinal side effects…
Recent research suggests that Ozempic-like medications, which include semaglutide, may influence alcohol cravings and consumption patterns. While some studies indicate a reduction…
Dr. Naresh Trehan emphasizes the importance of recognizing personal heart disease risks, highlighting that heart health is influenced by genetics, lifestyle choices, and biomarker…
In a recent conversation, Dr. Tyna Moore addresses the complexities surrounding GLP-1 medications, advocating for their use at low doses. She counters common misconceptions about…
This article explains the concept of controlling for variables in scientific studies, highlighting its significance in assessing the credibility of research findings. It discusses…
Dozens of lawsuits have been filed against the manufacturers of GLP-1 drugs like Ozempic and Wegovy, alleging that users were not adequately warned about the risk of a rare type o…
Recent lawsuits have emerged against the makers of GLP-1 drugs like Ozempic and Wegovy, alleging insufficient warnings about a rare vision loss condition known as NAION. While stu…
As GLP-1 medications gain popularity for weight loss, their use among college women during sorority recruitment raises concerns about body image pressures. A recent analysis indic…
A recent study investigates the effects of GLP-1 medications, such as Ozempic, on physical and mental health, employment, and relationships among adults with diabetes. While these…
The beauty industry is rapidly evolving in response to the adoption of GLP-1 weight-loss drugs, creating a new market for beauty products that promise to counteract the side effec…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…